FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Annora Pharma Private Lacosamide Tablets Recall

Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt

Annora Pharma Private Limited · Hyderabad, N/A

Risk level
Class II
Reported by FDA
Jul 1, 2026
Recall ID
D-0626-2026
Check your lot numberHow we source this data

Summary

Annora Pharma Private recalled Lacosamide Tablets starting Jun 4, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0626-2026 on Jul 1, 2026. Reason: Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg. Status: Ongoing.

Why it was recalled

Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.

Product description

Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.

Lot numbers, UPCs & expiration codes

Lot: A253999, A254000, Expires: 09/30/2027.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0626-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jun 4, 2026
FDA report date
Jul 1, 2026
Quantity
31,392 60-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Annora Pharma Private Limited

Original FDA data

Every field from FDA enforcement report D-0626-2026, exactly as published.

Show all FDA fields
City
Hyderabad
Status
Ongoing
Country
India
Event ID
99200
Address
Sy. No.261, Plot No. 13 And 14, Annaram Village, Gummadidal Mandal
Address (line 2)
Jinnaram Mandal, Sangareddy District, Medak
Code information
Lot: A253999, A254000, Expires: 09/30/2027.
Report date
Jul 1, 2026
Product type
Drugs
Recall number
D-0626-2026
Classification
Class II
Recalling firm
Annora Pharma Private Limited
Product quantity
31,392 60-count bottles
Reason for recall
Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.
Distribution pattern
Nationwide in the USA
Recall initiation date
Jun 4, 2026
Initial firm notification
E-Mail
Center classification date
Jun 25, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0626-2026, published Jul 1, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls